
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
α-Synuclein Conformational Strains as Drivers of Phenotypic Heterogeneity in Neurodegenerative Diseases
Raphaella W. L. So, Joel C. Watts
Journal of Molecular Biology (2023) Vol. 435, Iss. 12, pp. 168011-168011
Open Access | Times Cited: 17
Raphaella W. L. So, Joel C. Watts
Journal of Molecular Biology (2023) Vol. 435, Iss. 12, pp. 168011-168011
Open Access | Times Cited: 17
Showing 17 citing articles:
Parkinson disease therapy: current strategies and future research priorities
Fabrizio Stocchi, Daniele Bravi, Aron Emmi, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 12, pp. 695-707
Closed Access | Times Cited: 10
Fabrizio Stocchi, Daniele Bravi, Aron Emmi, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 12, pp. 695-707
Closed Access | Times Cited: 10
The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson’s disease
Heather H. C. Lau, Iván Martínez-Valbuena, Raphaella W. L. So, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 13
Heather H. C. Lau, Iván Martínez-Valbuena, Raphaella W. L. So, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 13
“Prion-like” seeding and propagation of oligomeric protein assemblies in neurodegenerative disorders
Silvia Zampar, Sonja E. Di Gregorio, Gustavo Grimmer, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 4
Silvia Zampar, Sonja E. Di Gregorio, Gustavo Grimmer, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 4
Unveiling the Cutting Edge: Recent Developments in α-Synuclein Nano-biosensor Technology for Precision Diagnosis of Parkinson’s Disease
Romi Shreshtha, Aditya Mulukutla, Vishal Kumar Deb, et al.
BioNanoScience (2025) Vol. 15, Iss. 1
Closed Access
Romi Shreshtha, Aditya Mulukutla, Vishal Kumar Deb, et al.
BioNanoScience (2025) Vol. 15, Iss. 1
Closed Access
Bridging Mechanical Properties with Atomic Structures of Polymorphic α‐Synuclein Fibrils by Single‐Molecule Analysis and Molecular Dynamics Simulations
Lulu Bi, Linge Li, Xiang Li, et al.
Aggregate (2025)
Open Access
Lulu Bi, Linge Li, Xiang Li, et al.
Aggregate (2025)
Open Access
TDP-43 seeding activity in the olfactory mucosa of patients with amyotrophic lateral sclerosis
Maria Vizziello, Ilaria Linda Dellarole, Arianna Ciullini, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
Maria Vizziello, Ilaria Linda Dellarole, Arianna Ciullini, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
The interplay of iron, oxidative stress, and α-synuclein in Parkinson’s disease progression
Yan Chen, Xixi Luo, Yonggao Yin, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Yan Chen, Xixi Luo, Yonggao Yin, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Chemical catalysis by biological amyloids
Pernilla Wittung‐Stafshede
Biochemical Society Transactions (2023) Vol. 51, Iss. 5, pp. 1967-1974
Open Access | Times Cited: 7
Pernilla Wittung‐Stafshede
Biochemical Society Transactions (2023) Vol. 51, Iss. 5, pp. 1967-1974
Open Access | Times Cited: 7
LRP10 and α-synuclein transmission in Lewy body diseases
Ana Carreras Mascaro, Martyna M. Grochowska, Valerie Boumeester, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 2
Ana Carreras Mascaro, Martyna M. Grochowska, Valerie Boumeester, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 2
Current insights and assumptions on α-synuclein in Lewy body disease
Rehana K. Leak, Rachel N. Clark, Muslim Abbas, et al.
Acta Neuropathologica (2024) Vol. 148, Iss. 1
Open Access | Times Cited: 2
Rehana K. Leak, Rachel N. Clark, Muslim Abbas, et al.
Acta Neuropathologica (2024) Vol. 148, Iss. 1
Open Access | Times Cited: 2
Abatacept inhibits Th17 differentiation and mitigates α-synuclein-induced dopaminergic dysfunction in mice
Julia R. Clarke, Thiago Sa Bacelar, Gabriel Gripp Fernandes, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 1
Julia R. Clarke, Thiago Sa Bacelar, Gabriel Gripp Fernandes, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 1
Liquid–liquid phase separation and conformational strains of α-Synuclein: implications for Parkinson’s disease pathogenesis
Eva D. Ruiz-Ortega, Anna Wilkaniec, Agata Adamczyk
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 1
Eva D. Ruiz-Ortega, Anna Wilkaniec, Agata Adamczyk
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 1
(Dys)functional insights into nucleic acids and RNA-binding proteins modulation of the prion protein and α-synuclein phase separation
Yraima Cordeiro, Maria Heloisa O. Freire, Adalgisa Felippe Wiecikowski, et al.
Biophysical Reviews (2023) Vol. 15, Iss. 4, pp. 577-589
Closed Access | Times Cited: 2
Yraima Cordeiro, Maria Heloisa O. Freire, Adalgisa Felippe Wiecikowski, et al.
Biophysical Reviews (2023) Vol. 15, Iss. 4, pp. 577-589
Closed Access | Times Cited: 2
Nonintuitive Immunogenicity and Plasticity of Alpha-Synuclein Conformers: A Paradigm for Smart Delivery of Neuro-Immunotherapeutics
Amos Olusegun Abioye, Damilare D. Akintade, James Mitchell, et al.
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 609-609
Open Access
Amos Olusegun Abioye, Damilare D. Akintade, James Mitchell, et al.
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 609-609
Open Access
Lipids and α-Synuclein: adding further variables to the equation
Jana Schepers, Timo Löser, Christian Behl
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Jana Schepers, Timo Löser, Christian Behl
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Species barrier as molecular basis for adaptation of synthetic prions with N‐terminally truncated PrP
Human Rézaei, Davy Martin, Laëtitia Herzog, et al.
FEBS Journal (2024) Vol. 291, Iss. 22, pp. 5051-5076
Open Access
Human Rézaei, Davy Martin, Laëtitia Herzog, et al.
FEBS Journal (2024) Vol. 291, Iss. 22, pp. 5051-5076
Open Access
LRP10 as a novel α-synuclein regulator in Lewy body diseases
Ana Carreras Mascaro, Martyna M. Grochowska, Valerie Boumeester, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Ana Carreras Mascaro, Martyna M. Grochowska, Valerie Boumeester, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Molecular Mechanisms of Neurodegeneration in Parkinson’s Disease
Jean‐François Trempe, Kalle Gehring
Journal of Molecular Biology (2023) Vol. 435, Iss. 12, pp. 168131-168131
Open Access
Jean‐François Trempe, Kalle Gehring
Journal of Molecular Biology (2023) Vol. 435, Iss. 12, pp. 168131-168131
Open Access
Protease-Sensitive and -Resistant Forms of Human and Murine Alpha-Synucleins in Distinct Brain Regions of Transgenic Mice (M83) Expressing the Human Mutated A53T Protein
Dominique Bétemps, Jean-Noël Arsac, Simon Nicot, et al.
Biomolecules (2023) Vol. 13, Iss. 12, pp. 1788-1788
Open Access
Dominique Bétemps, Jean-Noël Arsac, Simon Nicot, et al.
Biomolecules (2023) Vol. 13, Iss. 12, pp. 1788-1788
Open Access